$3.37
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGM:HBIO
Harvard Bioscience Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $595.30 | $591.94 | 0.00% | 1 | $227.24B |
| DHR | Danaher | NYSE | Outperform | $265.80 | $260.33 | 0.00% | 4 | $196.87B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $236.30 | $284.47 | 0.00% | 8 | $68.29B |
| LONN | Lonza Group | SWX | Buy | CHF529.20 | CHF516.89 | 0.00% | 8 | CHF38.16B |
| BIO | Bio-Rad Laboratories Inc | NYSE | Outperform | $293.85 | $536.80 | 0.00% | 1 | $7.92B |
| MXCT | MaxCyte | AIM | Buy | £3.75 | £9.66 | 0.00% | 6 | £303.18M |
